When it comes to controlling costs for prescription drugs, everybody wants to get into the act this year. With so ...

When biosimilars hit FDA, what will be the review criteria? Everyone cares, since so much is at stake. The market ...

Those who know me will raise an eyebrow, even drop a jaw, at hearing of the evolution from solo-based consulting ...

Folks may just waking up to the impact that health reform will have on their businesses. Not just doctors or ...